China's economy is fast developing - and many people fear that IP protection cannot keep up. International investors are concerned about effective enforcement, while domestic companies seek a strong environment for developing IP rights and negotiating on issues such as standards. MIP and Finnegan Henderson jointly hosted a roundtable discussion in Beijing last month to discuss how these issues can be addressed. Read the full, unabridged transcript exclusively here on managingip.com.
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
Publication of the UPC’s annual report and adoption of the procedural rules of the Patent Mediation and Arbitration Centre were also among major developments